BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35514287)

  • 1. Safety and Effectiveness of Excimer Laser Ablation Combined With Drug-Coated Balloon for Atherosclerotic Obliterans in the Lower Extremity.
    Jiang X; Ju S; Chen B; Jiang J; Shi Y; Ma T; Lin C; Xu X; Fu W; Dong Z
    J Endovasc Ther; 2023 Oct; 30(5):721-729. PubMed ID: 35514287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application and value of excimer laser ablation in the treatment of lower limb atherosclerotic obliterans].
    Jiang XL; Ju S; Chen B; Jiang JH; Shi Y; Ma T; Lin CP; Guo DQ; Xu X; Dong ZH; Fu WG
    Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(14):1026-1030. PubMed ID: 33845542
    [No Abstract]   [Full Text] [Related]  

  • 3. Excimer laser ablation combined with drug-coated balloon versus drug-coated balloon in the treatment of de novo atherosclerotic lesions in lower extremities (ELABORATE): study protocol for a real-world clinical trial.
    Jiang X; Fan L; Chen B; Jiang J; Liu J; Qiao G; Ju S; Shi Y; Ma T; Lin C; Fang G; Guo D; Xu X; Dong Z; Fu W
    BMC Cardiovasc Disord; 2022 Jul; 22(1):317. PubMed ID: 35842583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of Excimer Laser Ablation Combined with Drug-Coated Balloon for Atherosclerotic Obliterans of Lower Extremity and Risk Factors for Loss of Primary Patency.
    Jiang X; Li X; Chen B; Jiang J; Shi Y; Ma T; Lin C; Guo D; Xu X; Ju S; Fu W; Dong Z
    Ann Vasc Surg; 2023 Apr; 91():223-232. PubMed ID: 36584966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Excimer Laser Ablation Combined with Drug-coated Balloon in Atherosclerotic Lesions of the Popliteal Artery.
    Jiang X; Ju S; Liu H; Chen B; Jiang J; Shi Y; Ma T; Lin C; Fang G; Guo D; Xu X; Fu W; Dong Z
    Ann Vasc Surg; 2024 Jul; 104():196-204. PubMed ID: 38492729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis).
    Dippel EJ; Makam P; Kovach R; George JC; Patlola R; Metzger DC; Mena-Hurtado C; Beasley R; Soukas P; Colon-Hernandez PJ; Stark MA; Walker C;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):92-101. PubMed ID: 25499305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Excimer Laser Atherectomy Combined with a Drug-Coated Balloon in De Novo Femoral Popliteal Artery Disease: A Retrospective Study.
    Pan D; Guo J; Su Z; Meng W; Wang C; Guo J; Gu Y
    Ann Vasc Surg; 2024 Feb; 99():26-32. PubMed ID: 37914073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and efficacy of different endovascular treatments for in-stent restenosis of the femoropopliteal artery: A network meta-analysis.
    He Z; Wang H; Lin F; Ding W; Chen K; Zhang Z
    Vasc Med; 2022 Jun; 27(3):239-250. PubMed ID: 35164613
    [No Abstract]   [Full Text] [Related]  

  • 9. Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of femoropopliteal arteriosclerosis obliterans.
    Su Z; Li Y; Yang S; Guo J; Guo L; Gu Y
    Ann R Coll Surg Engl; 2022 Nov; 104(9):667-672. PubMed ID: 35446161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort.
    Brodmann M; Keirse K; Scheinert D; Spak L; Jaff MR; Schmahl R; Li P; Zeller T;
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2113-2123. PubMed ID: 29050631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application value of excimer laser ablation combined with drug-coated balloon in non-stent atherosclerotic lesions of lower extremity arteries].
    Jiang XL; Li XY; Chen B; Jiang JH; Shi Y; Ma T; Lin CP; Fang G; Guo DQ; Xu X; Dong ZH; Fu W
    Zhonghua Wai Ke Za Zhi; 2022 Dec; 60(12):1057-1062. PubMed ID: 36480872
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
    Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
    J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Foley TR; Cotter RP; Kokkinidis DG; Nguyen DD; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
    Giannopoulos S; Ghanian S; Parikh SA; Secemsky EA; Schneider PA; Armstrong EJ
    J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
    [No Abstract]   [Full Text] [Related]  

  • 16. IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population.
    Chen Z; Guo W; Jiang W; Wang F; Fu W; Zou Y; Deckers S; Li P; Popma JJ; Jaff MR
    J Endovasc Ther; 2019 Aug; 26(4):471-478. PubMed ID: 31204595
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimal Intraluminal Drug-Coated Balloon Versus Drug-Eluting Stent in Patients With Chronic Total Occlusion of the Superficial Femoral Artery: A Retrospective Analysis.
    Hayakawa N; Kodera S; Takanashi K; Kanagami T; Ichihara S; Arakawa M; Hirano S; Inoguchi Y; Shakya S; Kanda J
    Cardiovasc Revasc Med; 2022 Oct; 43():87-96. PubMed ID: 35469761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM; Hyder ON; Soukas PA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
    Liistro F; Grotti S; Porto I; Angioli P; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
    Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G
    J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.